Abiraterone 250mg Zecyte Tablet is a type of antiandrogen medicine which is prescribed for treatment of prostate cancer. It is known to exert its antiandrogenic activity by inhibiting CYP17A1 enzyme which is expressed in prostatic tumor tissues. This tablet comprises abiraterone acetate as active chemical with molecular formula C26H33NO2 and molar mass of 391.555 g/mol. It shows around 99.8% of albumin binding ability with about 50% bioavailability. Abiraterone 250mg Zecyte Tablet gets metabolized by certain enzymes including esterases, CYP3A4, and SULT2A1. It is also known to have elimination half life of 12 to 24 hours with excretion mainly in feces.
250mg Zecyte Tablet
Product Details:
Brand |
CIPLA |
Content |
Abiraterone Acetate 250mg |
Dosage Form |
Tablets |
Dose |
Abiraterone Acetate 250mg |
Dose/Strength |
Abiraterone Acetate 250mg |
Dose/Strength (ex. 1 mg or 1 ml) |
Abiraterone Acetate 250mg |
Gender |
Unisex |
Manufactured By |
Cipla |
No of tablets |
120 TABLETS |
Packaging Size |
120 TABLETS |
Packaging Type |
BOTTLE |
Product Type |
Anti cancer Medicines |
Storage Condition |
Room Temperature |
Usage |
Commercial, Clinical, Hospital, Personal |
How to use Zecyte Tablet Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Zecyte 250mg Tablet is to be taken empty stomach
Additional Information:
SURETY HEALTHCARE
All Rights Reserved.(Terms of Use) Developed and Managed by Infocom Network Private Limited. |